187 related articles for article (PubMed ID: 27149649)
1. CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition.
Kapur N; Mir H; Clark Iii CE; Krishnamurti U; Beech DJ; Lillard JW; Singh S
Br J Cancer; 2016 Jun; 114(12):1343-51. PubMed ID: 27149649
[TBL] [Abstract][Full Text] [Related]
2. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
[TBL] [Abstract][Full Text] [Related]
3. The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer.
Zhang J; Zhu D; Lv Q; Yi Y; Li F; Zhang W
Tumour Biol; 2015 Dec; 36(12):9763-7. PubMed ID: 26156805
[TBL] [Abstract][Full Text] [Related]
4. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis.
Liu W; Wang W; Wang X; Xu C; Zhang N; Di W
Cancer Lett; 2020 Mar; 472():59-69. PubMed ID: 31866467
[TBL] [Abstract][Full Text] [Related]
6. TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer.
Coperchini F; Pignatti P; Carbone A; Bongianino R; Di Buduo CA; Leporati P; Croce L; Magri F; Balduini A; Chiovato L; Rotondi M
Tumour Biol; 2016 Apr; 37(4):5569-75. PubMed ID: 26577851
[TBL] [Abstract][Full Text] [Related]
7. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
[TBL] [Abstract][Full Text] [Related]
8. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
9. Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition.
Liu J; Zheng X; Deng H; Xu B; Chen L; Wang Q; Zhou Q; Zhang D; Wu C; Jiang J
Oncotarget; 2017 Dec; 8(70):115244-115253. PubMed ID: 29383156
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.
Liu B; Jia Y; Ma J; Wu S; Jiang H; Cao Y; Sun X; Yin X; Yan S; Shang M; Mao A
Acta Biochim Biophys Sin (Shanghai); 2016 Dec; 48(12):1067-1074. PubMed ID: 27797715
[TBL] [Abstract][Full Text] [Related]
11. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract][Full Text] [Related]
12. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
[TBL] [Abstract][Full Text] [Related]
13. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
[TBL] [Abstract][Full Text] [Related]
14. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
15. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
16. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
Lu E; Su J; Zhou Y; Zhang C; Wang Y
Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
[TBL] [Abstract][Full Text] [Related]
17. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
Zeng W; Chang H; Ma M; Li Y
Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
[TBL] [Abstract][Full Text] [Related]
18. Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway.
Chang YJ; Chen WY; Huang CY; Liu HH; Wei PL
Tumour Biol; 2015 Mar; 36(3):1859-69. PubMed ID: 25431258
[TBL] [Abstract][Full Text] [Related]
19. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
20. Paracrine CCL20 loop induces epithelial-mesenchymal transition in breast epithelial cells.
Marsigliante S; Vetrugno C; Muscella A
Mol Carcinog; 2016 Jul; 55(7):1175-86. PubMed ID: 26154142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
